ST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki

dc.contributor.author Bayramoğlu, Adil
dc.date.accessioned2026-02-20T12:29:37Z
dc.date.available2026-02-20T12:29:37Z
dc.date.issued2024
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı
dc.descriptionYıl : 2024 Cilt : 14 Sayı : 3 Sayfa : 152-159 Metin Dili : İngilizce
dc.description.abstractDeveloping contrast induced nephropathy after primary PCI in patients with ST segment elevation myocardial infarction is a risky condition in terms of mortality and morbidity. Various studies have shown that the systemic inflammatory index predicts (SII) the development of CIN. Mean platelet volume (MPV) is an important indicator known to be associated with the platelet function and activation. Therefore, we revised SII and named it modified SII (mSII) by using NLR multiply MPV. Material and Methods: This study includes patients who underwent pPCI due to STEMI in our cardiology department between February 2015 and February 2021. Modified SII was obtained by using MPV instead of platelet in the formula (mSII= NLR x MPV). Patients who underwent pPCI with STEMI were divided into two groups, those with CIN and those without CIN, and compared. Informed consent was obtained from all patients. Results: In the logistic regression analysis, it was observed that the mSII, NLR, GFR and contrast medium amount was independent predictor of CIN. The optimal threshold mSII for predicting CIN was >42.5, with a 78.1% sensitivity and 52.3% specificity ([AUC]: 0.639, 95%CI: 0.602- 0.674, p< 0.001). Pairwise comparison of ROC curves, it was observed that the predictive value of mSII for the development of CIN was better than NLR. (z-test = 3.144, P = 0.001) Conclusion: We think that mSII, which we have shown to be superior to SII in predicting the development of CIN and is very easy to calculate, is a parameter that can be considered in predicting the development of CIN after pPCI in STEMI patients.
dc.identifier.citationÖZDEMIR, L., BAYRAMOĞLU, A. (2024). RELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. Bozok Tıp Dergisi, 14(3),152-159. doi.org/10.16919/bozoktip.1500131
dc.identifier.endpage159
dc.identifier.issue3
dc.identifier.startpage152
dc.identifier.urihttps://hdl.handle.net/11616/106393
dc.identifier.volume14
dc.institutionauthorBayramoğlu, Adil
dc.language.isoen
dc.publisherİnönü Üniversitesi
dc.relation.ispartofBozok Tıp Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectNephropathy
dc.subjectContrast Agent
dc.subjectSystemic Inflammatory Index
dc.titleST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki
dc.title.alternativeRELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
document (43).pdf
Boyut:
318.63 KB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: